Limited Availability: $799 preorder (reg. $1,299). Save $500. Reserve for $49 →
Home
The Science
Cancer
How It Works
Pricing
About
Contact
EN FR DE 简体 繁體
Reserve Your Test for $49
miCheckup hero background

The best time to find cancer
is before it finds you. Waiting for symptoms isn't a plan.

Powered by microRNA science, the 2024 Medicine Nobel Prize winning discovery.

Close-up of a clinician drawing blood into a collection tube at a modern Canadian clinic
Now Available in Canada

One blood draw. Multiple cancers. An early warning powered by microRNA.

miCheckup is built on a microRNA multi-disease screening (MMDS) platform — a new approach to health screening that reads molecular signals from a single blood draw. Today, miCheckup applies that platform to cancer as a multi-cancer early detection (MCED) test, analyzing your blood for signals associated with multiple solid tumor cancers before symptoms appear. If a signal is identified, a complete whole-body MRI is included at no additional cost.

  • One blood draw at a partner collection centre — same as routine bloodwork.
  • Whole-body MRI included if a suspected cancer signal is found — a $4,000+ procedure, at no additional cost.
  • Physician-guided throughout. Results reviewed with you by a physician.
Reserve Your Test for $49

Preorder $799 · Regular $1,299 · Save $500

How It Works
Whole-body MRI scanner in a modern Canadian medical imaging facility
Included
$0
No additional cost
Included with Every Test

If a suspected cancer signal is found, you get a whole-body MRI for follow-up.

Not a referral letter. Not another invoice. Not a waitlist. A complete whole-body MRI — the same imaging a private clinic would charge you $4,000+ for — is included in your miCheckup MCED test at no additional cost.

$0
Your additional cost if a suspected cancer signal is found — whole-body MRI already included in your miCheckup test
>$4,000
Typical out-of-pocket cost for a private whole-body MRI in Canada

A physician reviews your imaging with you and works alongside your family doctor to guide you through every next step — from follow-up imaging to specialist referral within the Canadian healthcare system, where diagnosis and treatment happen.

Reserve Your Test for $49

Preorder $799 · Regular $1,299 · Save $500

How It Works

Four simple steps. One blood draw.

From ordering online to reviewing your results with a physician — miCheckup is designed to be simple and guided every step of the way.

Person ordering a health test on their laptop at a kitchen table
Modern blood collection clinic interior with patient and clinician
Laboratory technician analyzing blood samples with advanced scientific equipment
Patient and physician having a reassuring video consultation
01
/04

Order Your miCheckup Test Online

Visit micheckup.com and reserve your test in minutes. A $49 deposit secures the $799 preorder price before the regular $1,299 price returns. No family doctor referral required.

Reserve for $49
02
/04

Get a Simple Blood Draw

Book a convenient time at a partner collection centre near you. The blood draw takes about 10 minutes — same as routine bloodwork. No fasting required. Multiple locations across Ontario.

View Locations
03
/04

Your microRNA Is Analyzed for Suspected Cancer Signals

Your sample is analyzed for microRNA patterns associated with multiple solid tumor cancers — using validated algorithms trained on thousands of peer-reviewed blood samples. Processed entirely within Canada at an accredited Canadian laboratory.

04
/04

Receive Your Physician-Reviewed Results

In approximately 4–8 weeks, a physician walks you through your results. If a suspected cancer signal is found, your whole-body MRI is included, and you're guided into the Canadian healthcare system for next steps.

Learn More
Person ordering a health test on their laptop at a kitchen table
01/04

Order Your miCheckup Test Online

Visit micheckup.com and reserve your test in minutes. A $49 deposit secures the $799 preorder price before the regular $1,299 price returns. No family doctor referral required.

Reserve for $49
Modern blood collection clinic interior with patient and clinician
02/04

Get a Simple Blood Draw

Book a convenient time at a partner collection centre near you. The blood draw takes about 10 minutes — same as routine bloodwork. No fasting required. Multiple locations across Ontario.

View Locations
Laboratory technician analyzing blood samples with advanced scientific equipment
03/04

Your microRNA Is Analyzed for Suspected Cancer Signals

Your sample is analyzed for microRNA patterns associated with multiple solid tumor cancers — using validated algorithms trained on thousands of peer-reviewed blood samples. Processed entirely within Canada at an accredited Canadian laboratory.

Patient and physician having a reassuring video consultation
04/04

Receive Your Physician-Reviewed Results

In approximately 4–8 weeks, a physician walks you through your results. If a suspected cancer signal is found, your whole-body MRI is included, and you're guided into the Canadian healthcare system for next steps.

Learn More

The screening gap in Canada.

240,000+
New cancer cases per year in Canada — a number that continues to rise
Very Few
Of the cancers miCheckup tests for, very few have any public screening program in Canada
99%+
Specificity — fewer than 1 in 100 people without cancer receive a false signal

Most cancers have no screening test. miCheckup changes that.

Validated on thousands of peer-reviewed blood samples. Published in Scientific Reports (Nature Portfolio) and Cancers (MDPI). Powered by microRNA science, the 2024 Medicine Nobel Prize winning discovery.

Reserve Your Test for $49

Preorder $799 · Regular $1,299 · Save $500

The Science

microRNA — the molecular language your body already speaks.

microRNAs are tiny molecules that regulate gene expression in every cell. When disease develops, your microRNA patterns change — and those changes show up in your blood.

The 2024 Nobel Prize in Physiology or Medicine was awarded for the discovery of microRNA — the regulatory molecules at the heart of miCheckup's technology.3 These molecules cross the blood-brain barrier, escape from tumours, and circulate freely in your bloodstream. They are your body's earliest molecular signals.

miCheckup analyzes thousands of circulating microRNA data points in a standard blood sample, looking for patterns associated with cancer biology. The result is an early warning — not a diagnosis — that can identify a suspected cancer signal before symptoms appear.45

This is a microRNA multi-disease screening (MMDS) platform. Today, it detects signals across multiple solid tumor cancers as a multi-cancer early detection (MCED) test. The same molecular data may one day extend into cardiovascular and neurological health — because microRNA patterns change with all disease, not just cancer.

Explore the Science
Advanced molecular analysis equipment in a clean research laboratory with warm lighting
Multiple Cancers

For people who don't want to wait for a symptom.

miCheckup is built for adults who want to take a proactive role in their cancer screening — without needing a reason, a referral, or a family history.

Canada's healthcare system is world-class once you're sick. But it wasn't designed to catch cancer this early. miCheckup is the layer that comes before — a multi-cancer early detection test for adults who want an assessment of their cancer risk before symptoms appear.

miCheckup is especially valuable if:

  • You want a baseline cancer screening beyond the very few cancers with public screening programs in Canada
  • Cancer runs in your family, and you've been told there's nothing to do but wait and hope
  • Your doctor has said "there's no test for that" — for pancreatic, ovarian, liver, or other cancers with no public screening
  • You just want to know — and to have a clear next step within the Canadian healthcare system if a suspected cancer signal is found

miCheckup is not a diagnostic test. If a suspected cancer signal is found, your included whole-body MRI and physician review are the pathway into the public healthcare system — where diagnosis and treatment happen.6

View the Cancers We Test For
Confident person in natural light considering their health options thoughtfully
Common Questions

What people ask about miCheckup.

The most common questions from Canadians considering their first miCheckup test.

View How It Works
Aerial view of Canadian forest and river landscape in warm afternoon light

What does miCheckup test for?

Read Less
miCheckup is a microRNA multi-cancer early detection (MCED) test that screens for signals across multiple solid tumor cancers from a single blood draw — including pancreatic, ovarian, liver, kidney, lung, bladder, and other cancers that have no public screening program in Canada.
Person gazing forward with quiet determination and warm golden light behind them

In Canada, cancer treatment is free.The hard part is finding cancer early enough to have the best options.That's what miCheckup is for.

Reserve Your Test for $49

Preorder $799 · Regular $1,299 · Save $500

Important Safety Information

+

miCheckup is intended for adults at or above the age of majority in their province (18 or older in most provinces; 19 or older in British Columbia, New Brunswick, Newfoundland and Labrador, Nova Scotia, Northwest Territories, Nunavut, and Yukon). miCheckup is a multi-cancer early detection (MCED) test — an early warning test intended to identify a suspected cancer signal associated with multiple solid tumor cancers from a single blood draw. miCheckup does not detect all cancers and should be used in addition to routine cancer screening tests recommended by your healthcare provider.

Use of miCheckup is not recommended in individuals who are pregnant or planning pregnancy, under the age of majority in their province, currently undergoing active cancer treatment, or currently experiencing symptoms that may indicate cancer. If you are experiencing symptoms, please consult your physician directly.

Results should be interpreted by a healthcare provider in the context of your medical history, clinical signs, and symptoms. All miCheckup results are reviewed with you by a physician. A result of "no suspected cancer signal identified" does not rule out cancer. A result of "suspected cancer signal identified" is not a diagnosis — it requires confirmatory diagnostic evaluation by medically established procedures, which is why a whole-body MRI and physician follow-up are included in your miCheckup test.

If a suspected cancer signal is identified but cancer is not confirmed with further testing, it could mean that cancer is not present, or that testing was insufficient to detect cancer — including due to the cancer being located in an area or of a type not well represented in the miCheckup signal. False positive results (a suspected cancer signal identified when cancer is not present) and false negative results (no suspected cancer signal identified when cancer is present) do occur.

miCheckup is a complement to, not a replacement for, standard cancer screening programs. Continue all recommended screening — including mammography, Pap/HPV testing, and colorectal screening (FIT or colonoscopy) — as directed by your healthcare provider. Cancer diagnosis in Canada always requires a tissue biopsy confirmed by a pathologist. If a suspected cancer signal is identified, imaging and clinical workup by your healthcare team will determine the actual status. Many findings turn out to be benign after further investigation.

Laboratory/Test Information

+

miCheckup is a multi-cancer early detection (MCED) Laboratory-Developed Test (LDT), performed at an accredited Canadian medical laboratory certified by the Institute for Quality Management in Healthcare (IQMH). In Canada, LDTs are regulated as a clinical laboratory service under provincial and territorial laboratory oversight. Your blood sample is collected, processed, and analyzed entirely within Canada.

The miCheckup microRNA analysis is based on peer-reviewed research published in Scientific Reports (Nature Portfolio, 2024) and Cancers (MDPI, 2022), validated on thousands of peer-reviewed blood samples, with ongoing validation through the Ontario Health Study using 4,000+ Canadian blood samples.

Published validation shows greater than 99% specificity and greater than 90% sensitivity for the majority of cancer types in the current miCheckup panel of multiple solid tumor cancers. Performance may vary by cancer type and individual factors. For a detailed breakdown of sensitivity and specificity by cancer type, and the complete list of cancers currently in the miCheckup panel, visit The Science.

All personal health data is stored in Canada and handled in accordance with the Personal Information Protection and Electronic Documents Act (PIPEDA) and applicable provincial health privacy legislation, including the Personal Health Information Protection Act (PHIPA) in Ontario.

miCheckup is currently available in Ontario, expanding across Canada. For the full safety, regulatory, and performance disclosure, see Important Information.

References

+
  1. Thériault, G. et al. "Cancer screening in Canada: What's in, what's out, what's coming." Canadian Family Physician 67(1), 27–29 (2021). pmc.ncbi.nlm.nih.gov
  2. Canadian Cancer Society. Canadian Cancer Statistics 2024. cancer.ca/statistics
  3. The Nobel Assembly at Karolinska Institutet. "The Nobel Prize in Physiology or Medicine 2024." nobelprize.org
  4. Zhang J, Rui H, Hu H. "Noninvasive multi-cancer detection using blood-based cell-free microRNAs." Scientific Reports 14, 22136 (2024). doi.org
  5. Zhang A, Hu H. "A Novel Blood-Based microRNA Diagnostic Model with High Accuracy for Multi-Cancer Early Detection." Cancers 14(6), 1450 (2022). doi.org
  6. Canadian Cancer Society. "Benefits and limitations of regular cancer screening." cancer.ca